AngioDynamics Inc
NASDAQ:ANGO

Watchlist Manager
AngioDynamics Inc Logo
AngioDynamics Inc
NASDAQ:ANGO
Watchlist
Price: 8.69 USD -1.92%
Market Cap: 353.1m USD
Have any thoughts about
AngioDynamics Inc?
Write Note

AngioDynamics Inc
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

AngioDynamics Inc
Other Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
AngioDynamics Inc
NASDAQ:ANGO
Other Equity
-$3.3m
CAGR 3-Years
N/A
CAGR 5-Years
-17%
CAGR 10-Years
-11%
Becton Dickinson and Co
NYSE:BDX
Other Equity
$25.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Other Equity
-$128m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Other Equity
-$545m
CAGR 3-Years
13%
CAGR 5-Years
0%
CAGR 10-Years
-21%
Abbott Laboratories
NYSE:ABT
Other Equity
-$7.8B
CAGR 3-Years
5%
CAGR 5-Years
0%
CAGR 10-Years
-10%
Intuitive Surgical Inc
NASDAQ:ISRG
Other Equity
$23.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
37%
No Stocks Found

AngioDynamics Inc
Glance View

Market Cap
356.3m USD
Industry
Health Care

AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 800 full-time employees. The company went IPO on 2004-05-27. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular Access (VA). Its Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products (Core) and Venous Insufficiency. Its OS product offerings includes a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation (IRE) technology, the NanoKnife System. Its portfolio of VA products includes peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies.

ANGO Intrinsic Value
6.43 USD
Overvaluation 26%
Intrinsic Value
Price

See Also

What is AngioDynamics Inc's Other Equity?
Other Equity
-3.3m USD

Based on the financial report for Aug 31, 2024, AngioDynamics Inc's Other Equity amounts to -3.3m USD.

What is AngioDynamics Inc's Other Equity growth rate?
Other Equity CAGR 10Y
-11%

Over the last year, the Other Equity growth was 43%.

Back to Top